BCL2L12

Existing Annotations Review

GO Term	Evidence	Action	Reason
GO:0005634 nucleus	IBA GO_REF:0000033	ACCEPT	Summary: BCL2L12 localizes to both cytoplasm and nucleus. Nuclear localization is functionally important as nuclear BCL2L12 forms complexes with p53 and inhibits p53 transcriptional activity (Stegh & DePinho, 2011; PMID:20837658). Reason: Nuclear localization is well-established and functionally significant. The IBA annotation is consistent with experimental evidence from PMID:20837658 showing nuclear localization in GBM models. Supporting Evidence: PMID:20837658 Bcl2L12 (for Bcl2-like 12) is a cytoplasmic and nuclear protein that is overexpressed in primary GBM file:human/BCL2L12/BCL2L12-deep-research-falcon.md model: Edison Scientific Literature
GO:1902166 negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator	IBA GO_REF:0000033	ACCEPT	Summary: BCL2L12 inhibits p53-dependent DNA damage-induced apoptosis through direct physical interaction with p53 in the nucleus, attenuating p53 transcriptional activity on target promoters including proapoptotic genes Noxa and PUMA (PMID:20837658). Reason: This is a core function of BCL2L12. The IBA annotation accurately captures the specific role of BCL2L12 in antagonizing p53-mediated intrinsic apoptotic signaling following DNA damage, as demonstrated experimentally. Supporting Evidence: PMID:20837658 nuclear Bcl2L12 physically and functionally interacts with the p53 tumor suppressor, as evidenced by the capacity of Bcl2L12 to...inhibit p53-dependent DNA damage-induced apoptosis...impede the capacity of p53 to bind some of its target gene promoters
GO:0006915 apoptotic process	IEA GO_REF:0000043	MODIFY	Summary: BCL2L12 is a bona fide anti-apoptotic protein with evolved mechanisms for apoptosis inhibition. The generic 'apoptotic process' annotation from the UniProt Apoptosis keyword is too vague - the protein specifically negatively regulates apoptosis. Reason: While BCL2L12 is legitimately involved in apoptotic processes as a Bcl-2 family member, this annotation should be more specific. The protein functions as an anti-apoptotic factor through caspase inhibition and p53 antagonism, not as a general participant in apoptosis. Proposed replacements: negative regulation of apoptotic process Supporting Evidence: PMID:22262180 Ectopic expression of GFP-fused BCL2L12 or BCL2L12A in U87MG cells leads to repression of apoptotic markers and protects against staurosporine (STS) insults, indicating an antiapoptotic role
GO:0042981 regulation of apoptotic process	IEA GO_REF:0000002	ACCEPT	Summary: BCL2L12 contains a Bcl-2-like superfamily domain (IPR036834) that correctly suggests involvement in apoptosis regulation. This is a valid but general annotation. Reason: The IEA annotation from InterPro domain mapping is appropriate as BCL2L12 does regulate apoptosis through its Bcl-2 family membership. More specific annotations (GO:0043066 negative regulation) are present to provide detailed function. This broader term acceptable as general context. Supporting Evidence: PMID:22262180 BCL2L12 has been reported to be involved in post-mitochondrial apoptotic events in glioblastoma
GO:0005515 protein binding	IPI PMID:29749471 GSK3β‑mediated Ser156 phosphorylation modulates a BH3‑like d...	REMOVE	Summary: This annotation captures BCL2L12 interaction with BAX (UniProtKB:Q07812) from the WITH/FROM field. BCL2L12 contains a BH3-like motif that mediates interactions with Bcl-2 family members. Reason: 'Protein binding' is too vague and uninformative. The specific interaction with BAX should be captured with a more informative term. The BH3-like motif mediates interactions with Bcl-2/Bcl-xL, and BAX interaction is documented in UniProt. A more appropriate annotation would be GO:0051434 (BH3 domain binding) or a specific protein binding term. Proposed replacements: BH3 domain binding Supporting Evidence: PMID:29749471 May 11. GSK3β‑mediated Ser156 phosphorylation modulates a BH3‑like domain in BCL2L12 during TMZ‑induced apoptosis and autophagy in glioma cells.
GO:0005515 protein binding	IPI PMID:33961781 Dual proteome-scale networks reveal cell-specific remodeling...	REMOVE	Summary: BioPlex proteome-scale interaction network detected BCL2L12 interaction with BAX (UniProtKB:Q07812). This is a large-scale high-throughput study. Reason: 'Protein binding' is uninformative. The interaction with BAX is valid but should be annotated with a more specific MF term such as BH3 domain binding, or as part of the biological process annotations. High-throughput data supports but does not add specificity. Proposed replacements: BH3 domain binding Supporting Evidence: PMID:33961781 2021 May 6. Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.
GO:0005515 protein binding	IPI Q9HB09-1 PMID:19376117 HSP70 protects BCL2L12 and BCL2L12A from N-terminal ubiquiti...	REMOVE	Summary: This annotation from PMID:19376117 captures the interaction between BCL2L12 and ubiquitin (UBC, UniProtKB:P0CG48). The study showed BCL2L12 is degraded through the ubiquitin-proteasome system via N-terminal ubiquitination, and HSP70 protects BCL2L12 from this degradation. Reason: 'Protein binding' is uninformative. The interaction with ubiquitin reflects BCL2L12 being a substrate for ubiquitination, not a core molecular function. The HSP70 interaction (which protects BCL2L12 from degradation) is more functionally relevant but also captured by this vague term. Supporting Evidence: PMID:19376117 HSP70 was identified to interact with BCL2L12 and BCL2L12A and protected them from ubiquitinations and degradations in mammalian cells
GO:0002039 p53 binding	IEA GO_REF:0000107	ACCEPT	Summary: BCL2L12 directly binds p53 in the nucleus, inhibiting p53 transcriptional activity on target gene promoters. This is a core molecular function essential for BCL2L12's anti-apoptotic activity (PMID:20837658). Reason: p53 binding is a well-documented core function of BCL2L12. The IEA annotation (transferred from mouse ortholog) is accurate and supported by experimental evidence in human cells showing physical and functional interaction. Supporting Evidence: PMID:20837658 nuclear Bcl2L12 physically and functionally interacts with the p53 tumor suppressor
GO:0043066 negative regulation of apoptotic process	IDA PMID:22262180 GSK3β regulates Bcl2L12 and Bcl2L12A anti-apoptosis signalin...	ACCEPT	Summary: BCL2L12 is a bona fide anti-apoptotic protein. PMID:22262180 demonstrated that ectopic expression of BCL2L12 or BCL2L12A in U87MG glioma cells represses apoptotic markers and protects against staurosporine-induced apoptosis. GSK3beta phosphorylation at Ser156 is required for this anti-apoptotic function. Reason: This is a core function of BCL2L12, well-supported by direct experimental evidence. BCL2L12 inhibits apoptosis through dual mechanisms: cytoplasmic effector caspase inhibition and nuclear p53 antagonism. Supporting Evidence: PMID:22262180 Ectopic expression of GFP-fused BCL2L12 or BCL2L12A in U87MG cells leads to repression of apoptotic markers and protects against staurosporine (STS) insults, indicating an antiapoptotic role for both BCL2L12 and BCL2L12A
GO:0016020 membrane	HDA PMID:19946888 Defining the membrane proteome of NK cells.	MARK AS OVER ANNOTATED	Summary: PMID:19946888 is a high-throughput membrane proteomics study of NK cells that identified 1843 proteins. BCL2L12 detection in membrane fractions is unexpected given that BCL2L12 lacks a transmembrane domain (unlike typical Bcl-2 family members). Reason: BCL2L12 is atypical among Bcl-2 family members in lacking a transmembrane domain. Its established localization is cytoplasm and nucleus, not membrane. The HDA detection in membrane fractions from a large-scale study likely represents contamination or transient association rather than functional membrane localization. The primary literature consistently describes BCL2L12 as cytoplasmic and nuclear. Supporting Evidence: PMID:20837658 Bcl2L12 (for Bcl2-like 12) is a cytoplasmic and nuclear protein PMID:19946888 Defining the membrane proteome of NK cells.
GO:0045944 positive regulation of transcription by RNA polymerase II	IDA PMID:22262180 GSK3β regulates Bcl2L12 and Bcl2L12A anti-apoptosis signalin...	UNDECIDED	Summary: This annotation suggests BCL2L12 positively regulates Pol II transcription. However, the primary literature describes BCL2L12 as inhibiting p53-mediated transcription, which would be negative regulation. The annotation may reflect indirect effects. Reason: The citation PMID:22262180 focuses on BCL2L12's anti-apoptotic role and GSK3beta regulation, not direct transcriptional regulation. BCL2L12's known transcriptional role is inhibiting p53 target gene transcription. Without access to the full text showing direct evidence for positive transcriptional regulation, this annotation requires further verification. Supporting Evidence: PMID:20837658 attenuate endogenous p53-directed transcriptomic changes following genotoxic stress PMID:22262180 GSK3β regulates Bcl2L12 and Bcl2L12A anti-apoptosis signaling in glioblastoma and is inhibited by LiCl.
GO:0005634 nucleus	IDA PMID:20837658 Glioma oncoprotein Bcl2L12 inhibits the p53 tumor suppressor...	ACCEPT	Summary: PMID:20837658 directly demonstrated nuclear localization of BCL2L12 and established that nuclear BCL2L12 physically interacts with p53 to inhibit its transcriptional activity on target gene promoters. Reason: Direct experimental evidence (IDA) for nuclear localization. Nuclear localization is functionally essential for BCL2L12's role in p53 antagonism. Supporting Evidence: PMID:20837658 Bcl2L12 (for Bcl2-like 12) is a cytoplasmic and nuclear protein that is overexpressed in primary GBM...nuclear Bcl2L12 physically and functionally interacts with the p53 tumor suppressor
GO:0043027 cysteine-type endopeptidase inhibitor activity involved in apoptotic process	TAS PMID:20837658 Glioma oncoprotein Bcl2L12 inhibits the p53 tumor suppressor...	NEW	Summary: BCL2L12 directly inhibits effector caspase-7 (and attenuates caspase-3 activation) downstream of mitochondrial permeabilization. This is a core molecular mechanism described in the deep research file (BCL2L12-deep-research-falcon.md). Reason: The deep research and literature consistently describe BCL2L12 as directly inhibiting effector caspases, particularly caspase-7. This function is not currently annotated but is well-documented in the literature as a core anti-apoptotic mechanism. Supporting Evidence: PMID:20837658 functions to inhibit post-mitochondrial apoptosis signaling
GO:0051434 BH3 domain binding	TAS PMID:22262180 GSK3β regulates Bcl2L12 and Bcl2L12A anti-apoptosis signalin...	NEW	Summary: BCL2L12 contains a BH3-like motif (residues ~192-220) that mediates binding to anti-apoptotic Bcl-2 family members (Bcl-2, Bcl-xL). Mutations in key residues (L213, L217) restore apoptosis signaling. Reason: The BH3-like motif is a characterized functional domain mediating protein-protein interactions with Bcl-2 family members. This is more informative than generic 'protein binding' for capturing BCL2L12's molecular function. Supporting Evidence: PMID:22262180 a BCL2L12(153-191) fragment located outside of the C-terminal BH2 motif is responsible for GSK3b binding